The Business Research Company’s Prostate Specific Antigen (PSA) Test Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Prostate Specific Antigen (PSA) Test Global Market Report 2023 evaluates prostate specific antigen (psa) test market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=12576&type=smp

The global prostate-specific antigen (PSA) test market is expected to grow from $3.24 billion in 2022 to $3.66 billion in 2023 at a compound annual growth rate (CAGR) of 13.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The prostate-specific antigen (PSA) test market is expected to reach $5.73 billion in 2027 at a CAGR of 11.8%.

The increasing prevalence of prostate cancer is expected to propel the growth of the prostate-specific antigen (PSA) test market going forward. Prostate cancer is a condition in which cancer arises in the prostate gland, a component of the male and female reproductive systems. The prostate-specific antigen (PSA) test is commonly used as a screening tool for prostate cancer in men. It measures the level of PSA in the bloodstream, which will help with early detection and risk assessment. For instance, in March 2023, according to the reports shared by the American Society of Clinical Oncology (ASCO), a US-based professional oncology organization, in the US, an estimated 288,300 men were diagnosed with prostate cancer, and approximately 34,700 people died in 2023. Further, in 2020, globally, an estimated 1,414,259 people will be diagnosed with prostate cancer. Therefore, the rise in the prevalence of prostate cancer is driving the growth of the prostate-specific antigen (PSA) test market.

Get More Information On The Prostate Specific Antigen (PSA) Test Market Report:

https://www.thebusinessresearchcompany.com/report/prostate-specific-antigen-psa-test-global-market-report

The prostate specific antigen (psa) test market segments in the report are:

1) By ype: Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Other Types

2) By Application: Screening, Post-Treatment Monitoring, Other Applications

3) By End User: Hospitals, Diagnostic Centers, Research Institutes, Other End Users

The table of contents in TBRC’s prostate specific antigen (psa) test market report includes:

Executive Summary
Prostate Specific Antigen (PSA) Test Market Characteristics
Prostate Specific Antigen (PSA) Test Market Trends And Strategies
Prostate Specific Antigen (PSA) Test Market - Macro Economic Scenario
Prostate Specific Antigen (PSA) Test Market Segmentation.
.

.

Global Prostate Specific Antigen (PSA) Test Market Competitive Benchmarking
Global Prostate Specific Antigen (PSA) Test Market Competitive Dashboard
Key Mergers And Acquisitions In The Prostate Specific Antigen (PSA) Test Market
Prostate Specific Antigen (PSA) Test Market Future Outlook and Potential Analysis
Appendix
Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.



Contact Us:


The Business Research Company


Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293



Email: [email protected]



Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model